People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phenomix Sciences, Inc. | — | Other Health Care | Series A | $8.6M | $7.1M | 2024 |
Mark Bengall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Bengall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Bagnall | 1 | 3 |
| LAWRENCE COHEN | 1 | 3 |
| Karl Ronn | 1 | 2 |
| Lawrence K Cohen | 1 | 2 |
| Michael Camilleri | 1 | 2 |
| Andres Acosta | 1 | 2 |
| Karl K Ronn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.